Details for New Drug Application (NDA): 206512
✉ Email this page to a colleague
The generic ingredient in AMLODIPINE BESYLATE AND VALSARTAN is amlodipine besylate; valsartan. There are fifty drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the amlodipine besylate; valsartan profile page.
Summary for 206512
Tradename: | AMLODIPINE BESYLATE AND VALSARTAN |
Applicant: | Aurobindo Pharma |
Ingredient: | amlodipine besylate; valsartan |
Patents: | 0 |
Suppliers and Packaging for NDA: 206512
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
AMLODIPINE BESYLATE AND VALSARTAN | amlodipine besylate; valsartan | TABLET;ORAL | 206512 | ANDA | Aurobindo Pharma Limited | 65862-737 | 65862-737-03 | 3 BLISTER PACK in 1 CARTON (65862-737-03) / 10 TABLET, FILM COATED in 1 BLISTER PACK (65862-737-10) |
AMLODIPINE BESYLATE AND VALSARTAN | amlodipine besylate; valsartan | TABLET;ORAL | 206512 | ANDA | Aurobindo Pharma Limited | 65862-737 | 65862-737-30 | 30 TABLET, FILM COATED in 1 BOTTLE (65862-737-30) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE;160MG | ||||
Approval Date: | Apr 22, 2016 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE;320MG | ||||
Approval Date: | Apr 22, 2016 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE;160MG | ||||
Approval Date: | Apr 22, 2016 | TE: | AB | RLD: | No |
Complete Access Available with Subscription